JP2013006854A5 - - Google Patents

Download PDF

Info

Publication number
JP2013006854A5
JP2013006854A5 JP2012191753A JP2012191753A JP2013006854A5 JP 2013006854 A5 JP2013006854 A5 JP 2013006854A5 JP 2012191753 A JP2012191753 A JP 2012191753A JP 2012191753 A JP2012191753 A JP 2012191753A JP 2013006854 A5 JP2013006854 A5 JP 2013006854A5
Authority
JP
Japan
Prior art keywords
halogen atom
alkyl group
thio
hydrogen atom
glucitol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012191753A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013006854A (ja
JP5660094B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012191753A priority Critical patent/JP5660094B2/ja
Priority claimed from JP2012191753A external-priority patent/JP5660094B2/ja
Publication of JP2013006854A publication Critical patent/JP2013006854A/ja
Publication of JP2013006854A5 publication Critical patent/JP2013006854A5/ja
Application granted granted Critical
Publication of JP5660094B2 publication Critical patent/JP5660094B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012191753A 2009-04-16 2012-08-31 併用医薬 Expired - Fee Related JP5660094B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012191753A JP5660094B2 (ja) 2009-04-16 2012-08-31 併用医薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2009100210 2009-04-16
JP2009100210 2009-04-16
JP2012191753A JP5660094B2 (ja) 2009-04-16 2012-08-31 併用医薬

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011540651A Division JP5077786B2 (ja) 2009-04-16 2010-04-16 併用医薬

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014245257A Division JP5910711B2 (ja) 2009-04-16 2014-12-03 併用医薬

Publications (3)

Publication Number Publication Date
JP2013006854A JP2013006854A (ja) 2013-01-10
JP2013006854A5 true JP2013006854A5 (enExample) 2013-05-30
JP5660094B2 JP5660094B2 (ja) 2015-01-28

Family

ID=42982643

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2011540651A Active JP5077786B2 (ja) 2009-04-16 2010-04-16 併用医薬
JP2012191753A Expired - Fee Related JP5660094B2 (ja) 2009-04-16 2012-08-31 併用医薬
JP2014245257A Active JP5910711B2 (ja) 2009-04-16 2014-12-03 併用医薬
JP2015253932A Active JP6066144B2 (ja) 2009-04-16 2015-12-25 併用医薬

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011540651A Active JP5077786B2 (ja) 2009-04-16 2010-04-16 併用医薬

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014245257A Active JP5910711B2 (ja) 2009-04-16 2014-12-03 併用医薬
JP2015253932A Active JP6066144B2 (ja) 2009-04-16 2015-12-25 併用医薬

Country Status (30)

Country Link
US (1) US20120040898A1 (enExample)
EP (3) EP2601949B1 (enExample)
JP (4) JP5077786B2 (enExample)
KR (2) KR20150046382A (enExample)
CN (7) CN105434430A (enExample)
AR (1) AR076317A1 (enExample)
AU (1) AU2010237748B2 (enExample)
BR (1) BRPI1012539A2 (enExample)
CA (1) CA2755392A1 (enExample)
CY (2) CY1114703T1 (enExample)
DK (2) DK2419097T3 (enExample)
ES (2) ES2523408T3 (enExample)
HK (6) HK1217301A1 (enExample)
HR (2) HRP20131120T1 (enExample)
ME (2) ME02015B (enExample)
MX (1) MX2011010901A (enExample)
MY (3) MY183793A (enExample)
NZ (4) NZ710575A (enExample)
PH (3) PH12015500235B1 (enExample)
PL (2) PL2419097T3 (enExample)
PT (2) PT2419097E (enExample)
RS (2) RS53056B (enExample)
RU (2) RU2532330C2 (enExample)
SG (6) SG2014012462A (enExample)
SI (2) SI2601949T1 (enExample)
SM (1) SMT201500015B (enExample)
TW (3) TW201500043A (enExample)
UA (2) UA111742C2 (enExample)
WO (1) WO2010119990A1 (enExample)
ZA (1) ZA201106727B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772191B2 (en) 2005-05-10 2010-08-10 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
WO2011039108A2 (en) 2009-09-30 2011-04-07 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives
US10610489B2 (en) 2009-10-02 2020-04-07 Boehringer Ingelheim International Gmbh Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
US20120283169A1 (en) * 2010-11-08 2012-11-08 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
TR201101809A1 (tr) * 2010-12-21 2012-07-23 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Vildagliptin ve glimepirid kombinasyonları.
US9192617B2 (en) 2012-03-20 2015-11-24 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
CN118453592A (zh) 2012-05-17 2024-08-09 Vtv治疗有限责任公司 用于治疗糖尿病的葡萄糖激酶活化剂组合物
US9320727B2 (en) * 2012-08-30 2016-04-26 Taisho Pharmaceutical Co., Ltd Combinations of SGLT 2 inhibitors and antihypertensive drugs
CA2812519A1 (en) 2013-04-05 2014-10-05 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US11813275B2 (en) 2013-04-05 2023-11-14 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
PT2981271T (pt) 2013-04-05 2019-02-19 Boehringer Ingelheim Int Utilizações terapêuticas de empagliflozina
HK1213818A1 (zh) 2013-04-05 2016-07-15 勃林格殷格翰国际有限公司 依帕列净的治疗用途
SI2986304T1 (sl) 2013-04-18 2022-04-29 Boehringer Ingelheim International Gmbh Farmacevtski sestavek, postopki za zdravljenje in njegove uporabe
TW201636015A (zh) * 2013-07-05 2016-10-16 卡地拉保健有限公司 協同性組成物
ES2869463T3 (es) * 2015-02-27 2021-10-25 Asan Found Composición para la prevención o tratamiento de la calcificación de válvulas que contiene un inhibidor de DPP-4
CN105963280B (zh) * 2016-06-30 2018-11-06 合肥华方医药科技有限公司 一种伏格列波糖口腔速溶膜及其制备方法
AU2017344882A1 (en) 2016-10-19 2019-03-28 Boehringer Ingelheim International Gmbh Combinations comprising an SSAO/VAP-1 inhibitor and a SGLT2 inhibitor, uses thereof
CN109922813A (zh) 2016-11-10 2019-06-21 勃林格殷格翰国际有限公司 药物组合物、治疗方法及其用途
WO2018086126A1 (zh) * 2016-11-14 2018-05-17 高雄医学大学 一种检测糖代谢异常的方法及其预防及治疗
AU2019254371A1 (en) 2018-04-17 2020-10-08 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
KR20190137343A (ko) 2018-06-01 2019-12-11 김유찬 계량 인덕션
WO2019241089A1 (en) 2018-06-12 2019-12-19 Vtv Therapeutics Llc Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
JP7425793B2 (ja) 2018-10-29 2024-01-31 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ピリジニルスルホンアミド誘導体、医薬組成物およびそれらの使用
CN112955215B (zh) 2018-10-29 2024-05-17 勃林格殷格翰国际有限公司 吡啶基磺酰胺衍生物、药物组合物及其用途
WO2021167840A1 (en) 2020-02-18 2021-08-26 Vtv Therapeutics Llc Sulfoxide and sulfone glucokinase activators and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4432757A1 (de) 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
JP2003520759A (ja) 1999-08-31 2003-07-08 アンドルックス ファーマスーティカルズ インコーポレーテッド 単位核を有する徐放性錠剤
ES2321815T3 (es) 2001-04-04 2009-06-12 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Combinacion terapeutica que comprende inhibidores de reabsorcion e glucosa y moduladores ppar.
DE60209343T2 (de) * 2001-04-11 2006-10-26 Bristol-Myers Squibb Co. Aminosäurekomplexe von c-arylglycosiden zur behandlung von diabetes und verfahren
TW200637839A (en) * 2005-01-07 2006-11-01 Taisho Pharmaceutical Co Ltd 1-thio-d-glucitol derivatives
US8115017B2 (en) * 2006-06-29 2012-02-14 Taisho Pharmaceutical Co., Ltd C-phenyl 1-thioglucitol compound
JP5194588B2 (ja) * 2006-07-06 2013-05-08 大正製薬株式会社 1−チオ−d−グルシトール誘導体を有効成分として含有する糖尿病の予防又は治療剤
WO2008020011A1 (en) * 2006-08-15 2008-02-21 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture
UA100008C2 (ru) * 2006-11-09 2012-11-12 Бьорінгер Інгельхайм Інтернаціональ Гмбх Комбинированное лечение ингибиторами sglt-2 (натрийзависимый сопереносчик глюкозы 2) и фармацевтической композицией, которая их содержит
CN101611023A (zh) * 2006-12-14 2009-12-23 大正制药株式会社 1-苯基1-硫代-d-山梨醇衍生物
CL2008002427A1 (es) 2007-08-16 2009-09-11 Boehringer Ingelheim Int Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2.
CL2008002425A1 (es) 2007-08-16 2009-09-11 Boehringer Ingelheim Int Composición farmacéutica que comprende un inhibidor de sglt2 y 1-(4-metil-quinazolin-2-il)metil-3metil-7-(-2-butin-1-il)-8-(3-(r)-amino-piperidin-1il)-xantina, un inhibidor de dpp iv y su uso para el tratamiento de la obesidad y de la diabetes tipo 1 y 2 y complicaciones de esta.

Similar Documents

Publication Publication Date Title
JP2013006854A5 (enExample)
RU2011146335A (ru) Фармацевтические композиции
EP2275108B1 (en) Pharmaceutical preparation comprising dpp-iv inhibitor and other diabetes therapeutic agent in concomitant or combined form
JP2011504903A5 (enExample)
JP2008007519A5 (enExample)
JP2011516477A5 (enExample)
JP2011509922A5 (enExample)
JP2012533546A5 (enExample)
CY1116799T1 (el) Προληψη της υπογλυκαιμιας σε ασθενεις με σακχαρωδη διαβητη τυπου 2
JP2005506352A5 (enExample)
JP2014500295A5 (enExample)
JP2018502101A5 (enExample)
JP2009542702A5 (enExample)
JP2013508279A5 (enExample)
JP2017505293A5 (enExample)
JP2018504393A5 (enExample)
CY1113755T1 (el) Η λιξισενατιδη ως επιπροσθετη αγωγη στην ινσουλινη γλαργινη και στη μετφορμινη για τη θεραπευτικη αντιμετωπιση του διαβητη τυπου 2
RU2013155586A (ru) [1,3]оксазины
JP2012530779A5 (enExample)
JP2016534124A5 (enExample)
JP2016505637A5 (enExample)
JP2015524472A5 (enExample)
JP2008519840A5 (enExample)
JP2015172098A5 (enExample)
RU2015125300A (ru) Производные фенотиазина и их применение против туберкулеза